Preprint Brief Report Version 1 This version is not peer-reviewed

Gene Therapy Approach for Treatment of Obese Agouti Mice

Version 1 : Received: 27 September 2024 / Approved: 27 September 2024 / Online: 29 September 2024 (11:08:10 CEST)

How to cite: Yunin, M. A.; Boychenko, S. S.; Lebedev, P. A.; Egorov, A. D. Gene Therapy Approach for Treatment of Obese Agouti Mice. Preprints 2024, 2024092320. https://doi.org/10.20944/preprints202409.2320.v1 Yunin, M. A.; Boychenko, S. S.; Lebedev, P. A.; Egorov, A. D. Gene Therapy Approach for Treatment of Obese Agouti Mice. Preprints 2024, 2024092320. https://doi.org/10.20944/preprints202409.2320.v1

Abstract

Obesity is a significant metabolic disorder associated with excessive fat accumu-lation and insulin resistance. In this study, we explored a gene therapy approach to treat obesity in agouti mice using adeno-associated viruses (AAVs) carrying PRDM16, FoxP4, or Follistatin (FST) genes, which are known to promote the browning of white adipose tissue. Mice treated with AAVs encoding PRDM16, FoxP4, or FST genes showed a reduction in body weight (9-12%) within the first three weeks after admin-istration, compared to control groups. Lipidomic analysis of adipose tissue revealed a dramatic reduction in triacylglycerol (TAG) species with low carbon number (40-54 acyl carbones) in treated mice.

Keywords

obesity; agouti mice; lipid profiling; TAG; mass spectrometry

Subject

Biology and Life Sciences, Endocrinology and Metabolism

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.